Hai Hua Bu

Chief Executive Officer at Shenzhen Arimab Biopharmaceuticals Co., Ltd.

48 year

Consumer Services

Health Technology

Process Industries

Profile

Hai Hua Bu is currently serving as a Director at Chengdu Hepatunn Pharmaceutical Co. Ltd., an Executive Director at Hepalink (Hong Kong) Co., Ltd., and as a General Manager & Director at Shenzhen Arimab Biopharmaceuticals Co., Ltd.
Prior to his current roles, he served as a Non-Executive Director at Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
from 2006 to 2021.
Mr. Bu holds an MBA from Shanghai Jiao Tong University and an undergraduate degree from Shanghai University of Finance & Economics.

Hai Hua Bu active positions

Companies	Position	Start
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million.	Director/Board Member	-
Hepalink (Hong Kong) Co., Ltd.	Director/Board Member	-
Shenzhen Arimab Biopharmaceuticals Co., Ltd.	Chief Executive Officer	-

All active positions of Hai Hua Bu

Former positions of Hai Hua Bu

Companies	Position	End
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.	Director/Board Member	2021-04-16

See the detail of Hai Hua Bu's experience

Training of Hai Hua Bu

Shanghai Jiao Tong University	Masters Business Admin
Shanghai University of Finance & Economics	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hai Hua Bu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.	Health Technology

Private companies	3
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million.	Process Industries
Hepalink (Hong Kong) Co., Ltd.
Shenzhen Arimab Biopharmaceuticals Co., Ltd.

See company connections